End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.15 MYR | 0.00% | -6.25% | -25.00% |
Mar. 26 | LYC Healthcare Lists Private Placement Shares on Malaysian Bourse | MT |
Mar. 01 | Lyc Healthcare Berhad Appoints Chong Sook Peng as Chief Financial Officer | CI |
Valuation
Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 100.7 | 105.6 | 60.41 | 105.7 | 113.8 | 169 |
Enterprise Value (EV) 1 | 89.26 | 110 | 83.82 | 175.8 | 215.7 | 243.5 |
P/E ratio | -16.9 x | -16.4 x | -5.81 x | -8.11 x | -11.6 x | -7.46 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 5.56 x | 13.9 x | 4.86 x | 4.06 x | 1.76 x | 1.83 x |
EV / Revenue | 4.92 x | 14.5 x | 6.74 x | 6.75 x | 3.34 x | 2.64 x |
EV / EBITDA | -17.6 x | -17.5 x | -11.9 x | -48.5 x | 21 x | 41.6 x |
EV / FCF | -11.8 x | -11.2 x | -10.6 x | -40.8 x | -17 x | 29.9 x |
FCF Yield | -8.48% | -8.95% | -9.41% | -2.45% | -5.88% | 3.35% |
Price to Book | 4.98 x | 4.6 x | 2.82 x | 5.41 x | 4.13 x | 3.6 x |
Nbr of stocks (in thousands) | 258,290 | 324,864 | 355,364 | 391,526 | 464,526 | 649,978 |
Reference price 2 | 0.3900 | 0.3250 | 0.1700 | 0.2700 | 0.2450 | 0.2600 |
Announcement Date | 7/31/18 | 7/31/19 | 8/27/20 | 7/30/21 | 7/29/22 | 7/28/23 |
Income Statement Evolution (Annual data)
Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 18.13 | 7.603 | 12.43 | 26.04 | 64.6 | 92.28 |
EBITDA 1 | -5.083 | -6.283 | -7.061 | -3.623 | 10.28 | 5.858 |
EBIT 1 | -5.322 | -7.222 | -8.583 | -5.767 | 7.639 | 2.585 |
Operating Margin | -29.36% | -94.99% | -69.03% | -22.15% | 11.83% | 2.8% |
Earnings before Tax (EBT) 1 | -5.406 | -7.57 | -10.22 | -11.5 | -1.221 | -11.86 |
Net income 1 | -5.18 | -5.928 | -9.7 | -12.05 | -9.227 | -19.19 |
Net margin | -28.57% | -77.97% | -78.01% | -46.29% | -14.28% | -20.79% |
EPS 2 | -0.0231 | -0.0199 | -0.0293 | -0.0333 | -0.0212 | -0.0349 |
Free Cash Flow 1 | -7.572 | -9.848 | -7.887 | -4.305 | -12.68 | 8.153 |
FCF margin | -41.77% | -129.53% | -63.43% | -16.54% | -19.62% | 8.84% |
FCF Conversion (EBITDA) | - | - | - | - | - | 139.19% |
FCF Conversion (Net income) | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 7/31/18 | 7/31/19 | 8/27/20 | 7/30/21 | 7/29/22 | 7/28/23 |
Balance Sheet Analysis
Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | - | 4.4 | 23.4 | 70.1 | 102 | 74.5 |
Net Cash position 1 | 11.5 | - | - | - | - | - |
Leverage (Debt/EBITDA) | - | -0.7006 x | -3.315 x | -19.35 x | 9.912 x | 12.71 x |
Free Cash Flow 1 | -7.57 | -9.85 | -7.89 | -4.31 | -12.7 | 8.15 |
ROE (net income / shareholders' equity) | -38.7% | -35.9% | -47.2% | -45.1% | -12.6% | -24.1% |
ROA (Net income/ Total Assets) | -12.4% | -12.3% | -10.8% | -3.72% | 2.99% | 0.81% |
Assets 1 | 41.9 | 48.27 | 89.89 | 324 | -308.5 | -2,369 |
Book Value Per Share 2 | 0.0800 | 0.0700 | 0.0600 | 0.0500 | 0.0600 | 0.0700 |
Cash Flow per Share 2 | 0.0300 | 0.0100 | 0.0100 | 0.0200 | 0.0300 | 0.0300 |
Capex 1 | 6.55 | 3.08 | 10.4 | 3.81 | 2.88 | 2.53 |
Capex / Sales | 36.15% | 40.47% | 83.38% | 14.61% | 4.46% | 2.74% |
Announcement Date | 7/31/18 | 7/31/19 | 8/27/20 | 7/30/21 | 7/29/22 | 7/28/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-25.00% | 22.63M | |
+17.18% | 85.55B | |
-28.48% | 70.07B | |
+6.76% | 28.95B | |
-7.44% | 17.51B | |
+2.14% | 17.39B | |
+2.10% | 15.38B | |
+7.02% | 13.4B | |
+64.96% | 12.93B | |
+6.64% | 12.77B |
- Stock Market
- Equities
- LYC Stock
- Financials LYC Healthcare